Skip to main content
OpenTrials
Completed

NCT Number: NCT06589193

Comparison of the Clinical and Microbiological Effects of CHX and HOCl Containing Mouthwashes

The primary objective of the study is to compare the antiplaque and anti-inflammatory effects of HOCl mouth rinse with those of CHX mouth rinse. The secondary objective is to evaluate and compare the antimicrobial activities of HOCl mouth rinse and CHX mouth rinse on dental biofilm.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Baskent University Faculty of Dentistry

Ankara, 06000, Turkey (Türkiye)

About this study

The primary objective of the current clinical study is to compare the antiplaque and anti-inflammatory efficacy of HOCl mouth rinse with that of CHX mouth rinse. The secondary objective is to compare the antimicrobial activities of these two mouth rinses on dental biofilm. This single-center, triple-blind, randomized controlled crossover study was completed with 26 participants. In the study, the same participants used both HOCl (0.02%) and CHX (0.2%) mouth rinses over a 4-day re-plaque formation model. Following each mouth rinse usage, supragingival dental plaque biofilm samples were collected, and clinical parameters including the Modified Plaque Index, Bleeding on Probing Index, and Modified Stain Index were recorded. Additionally, participants were asked to evaluate the mouth rinses they used via a questionnaire. In conclusion, HOCl mouth rinse has demonstrated antiplaque efficacy comparable to that of CHX mouth rinse. When evaluating total bacterial counts, both mouth rinses exhibited similar antimicrobial effectiveness. Within the limitations of this study, HOCl may be considered a promising antimicrobial agent for dental plaque control.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being systematically healthy
  • Having at least 22 natural teeth (236)
  • Not smoking
  • Participants must not drink alcohol and must work during their term

Exclusion criteria

  • Having periodontitis and gingivitis
  • Being breastfeeding or pregnant
  • Using medication that may affect periodontal status
  • Having used antibiotics in the last month
  • Having used any mouthwash in the last month
  • Using fixed, removable dentures or orthodontic appliances

Treatment and study plan

HOCl

Other

10ml,twice a day

CHX

Other

10ml,twice a day

Primary outcomes

  1. plaque index

    Time frame: 1 month

    Plaque index results were evaluated regionally and full mouth for CHX and HOCl groups.

Secondary outcomes

  1. microbiology

    Time frame: 1 month

    Microbiological data were evaluated on plaque samples taken from molar teeth for CHX and HOCl groups.

Sponsors and collaborators

Lead sponsor

Baskent University

Other

Registry information

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Sep 19, 2024
Registry last updated
Sep 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.